DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
8.20
+0.66 (8.75%)
At close: Feb 6, 2026, 4:00 PM EST
8.14
-0.06 (-0.73%)
After-hours: Feb 6, 2026, 4:00 PM EST

DiaMedica Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
3.333.034.544.734.717.41
Short-Term Investments
51.9941.1248.3528.7740.4120.1
Cash & Short-Term Investments
55.3244.1552.933.545.1127.51
Cash Growth
10.20%-16.54%57.89%-25.74%64.00%249.16%
Other Receivables
0.260.240.370.080.130.34
Receivables
0.260.240.370.080.130.34
Prepaid Expenses
0.450.230.410.210.080.06
Other Current Assets
0.2--0.040.110.01
Total Current Assets
56.2244.6153.6833.8445.4427.92
Property, Plant & Equipment
0.370.430.490.560.110.17
Other Long-Term Assets
-1.31----
Total Assets
57.0546.3554.1634.445.5528.1
Accounts Payable
1.920.940.930.730.511.1
Accrued Expenses
3.244.351.781.370.970.86
Current Portion of Leases
0.110.10.080.070.050.07
Total Current Liabilities
5.275.392.792.171.522.03
Long-Term Leases
0.160.240.320.400.05
Total Liabilities
5.435.633.12.571.532.08
Additional Paid-In Capital
215.6180.7166.61128.08126.5894.93
Retained Earnings
-164.03-140-115.56-96.18-82.5-68.91
Comprehensive Income & Other
0.050.020.01-0.07-0.05-0
Shareholders' Equity
51.6240.7251.0631.8344.0226.01
Total Liabilities & Equity
57.0546.3554.1634.445.5528.1
Total Debt
0.270.340.40.470.050.12
Net Cash (Debt)
55.0543.8152.533.0345.0627.39
Net Cash Growth
10.47%-16.55%58.92%-26.69%64.52%255.70%
Net Cash Per Share
1.231.081.611.252.171.75
Filing Date Shares Outstanding
52.0842.8637.9626.4626.4418.78
Total Common Shares Outstanding
52.0842.8237.9626.4426.4418.75
Working Capital
50.9639.2250.8931.6743.9225.89
Book Value Per Share
0.990.951.351.201.661.39
Tangible Book Value
51.6240.7251.0631.8344.0226.01
Tangible Book Value Per Share
0.990.951.351.201.661.39
Machinery
0.270.250.220.20.140.13
Leasehold Improvements
0.020.020.020.020-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q